Leaflet ARBALIOR 25mg / 5mg film-coated tablets

Product code:
W65955001
Quantity:
14
Indicated for:
heart failure
Route of administration:
oral
Substance:
metoprolol + ivabradine (beta blocker + cardiac If-current inhibitor)
ATC
C07FX05 — Cardiovascular system | Beta blocking agents | Beta blocking agents, other combinations

Precautions:

Dizziness / vertigo

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Hypotension / fall risk

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Elderly warning

Elderly warning

Older people may have an increased risk of side effects.

The combination of metoprolol and ivabradine is used for the treatment of chronic heart failure and stable angina pectoris. This combination combines a beta-blocker (metoprolol) and an If channel inhibitor (ivabradine) to reduce heart rate and improve cardiac function.

Metoprolol helps reduce the heart's oxygen demand, while ivabradine lowers the heart rate without affecting myocardial contractility. This leads to better heart perfusion and reduced angina symptoms.

The medication is administered as directed by a doctor, and the dose should be adjusted based on the patient's condition. It is important to monitor heart rate during treatment to avoid severe bradycardia.

Side effects may include dizziness, fatigue, or temporary visual disturbances. Patients with severe bradycardia, severe liver impairment, or allergies to any of the medication's components should avoid its use.

General data about ARBALIOR 25mg / 5mg

Substance:
metoprolol + ivabradine
Date of latest medicines list:
01-08-2019
Product code:
W65955001
Concentration:
25mg / 5mg
Pharmaceutical form:
film-coated tablets
Quantity:
14
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
LES LABORATOIRES SERVIER INDUSTRIE - FRANTA
Holder:
ANPHARM PRZEDSIEBIORSTWO FARMACEUTYCZNE S.A. - POLONIA
Number:
11643/2019/01
Shelf life:
30 months

Concentrations available for metoprolol + ivabradine

  • 25mg/5mg
  • 25mg/7.5mg
  • 50mg/5mg
  • 50mg/7.5mg